India's weight-loss drug boom: Novo Nordisk talks about GLP-1 generics after patent expiry
Published on March 20, 2026.
The patent on the controversial substance, known as "modernised," has expired in India on 20th century. The managing director of Novo.
. Furthermore, he expects an increase in 'Indian centennial' pricing to be made more accessible for the sake of the country.
Read Original Article